Alexa Norton
Biographic Data
| ID | 6094397 |
|---|---|
| NAME | Alexa Norton |
| GIVEN NAMES | Alexa |
| FAMILY NAME | Norton |
| SIGNATURE | NORTON A |
| AFFILIATIONS | University of Victoria |
| ORCID | 0000-0002-3226-3003 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Problem representation of the Risk Mitigation Guidance (RMG) within the context of dual public health emergencies of Covid-19 and toxic drug deaths in British Columbia, Canada
Our study builds on the importance of evaluating problem representations in the process of policymaking. The RMG illustrates how crisis-driven policymaking shapes problem representations, enabling rapid intervention through the COVID-19 response while constraining responses to the toxic drug emergency. As a medicalized emergency response, the RMG addressed contagion but failed to confront the structural drivers of toxic drug deaths. Our study hig…
Two-Eyed Seeing in Knowledge Synthesis: Weaving together Western scoping review methods with Indigenous storytelling to explore Indigenous approaches to harm reduction
Using methodological approaches rooted in Indigenous ways of knowing and being can help to ensure that research findings are relevant and useful to Indigenous communities, while providing evidence for more responsive public health policy and practice. This article explores a practical application of a Two-Eyed Seeing approach in knowledge synthesis as part of Phase I of the First Nation Health Authority’s Indigenizing Harm Reduction Study. The St…
Implementation Barriers and Outcomes of a Provincial Prescribed Safer Supply Initiative among Indigenous People who use Substances amid Covid-19 and a Toxic Drug Crisis in British Columbia, Canada
Background: In 2020, British Columbia (BC) introduced Risk Mitigation Guidance to support the provision of prescribed safer supply (PSS) to people at risk of toxic drug harms and death amid the COVID-19 pandemic. We sought to assess the self-reported barriers to and outcomes of PSS among Indigenous people who sought or accessed a prescription. Methods: Cross-sectional and longitudinal surveys with up to 5 time points per participant over 3 months…
Implementation of risk mitigation prescribing during dual public health emergencies: A qualitative study among Indigenous people who use drugs and health planners in Northern British Columbia, Canada
Implementation and access to risk mitigation prescribing in Northern BC was limited, with region-specific applicability challenges and a health service delivery model that was not able to sufficiently meet the unique service needs of IPWUD. Demonstrating Northern ingenuity, peer groups, harm reduction community champions, and telehealth services were identified as stopgap measures that promoted access and reduced inequitable implementation within…
Just have this come from their prescription pad: The medicalization of safer supply from the perspectives of health planners in BC, Canada
Context In March 2020, British Columbia introduced the Risk Mitigation Guidance (RMG) to enable the prescription of pharmaceutical substitutes for the unregulated drug market to decrease overdose deaths and COVID-19 infections. This study presents health planners’ perspectives on the RMG adoption within a medicalized system of care.Methods We conducted interviews with 28 health planners to obtain their views on implementation. We undertook a them…
A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada
Our findings demonstrate the value of including fentanyl patch safer supply in the substance use continuum of care and offer insights for innovations in delivery of this intervention
Putting Indigenous Harm Reduction to Work: Developing and Evaluating “Not Just Naloxone”
First Nations people and communities have long been championing the provision of holistic, self-determining, culturally safe, and responsive health care. In April 2016, a catastrophic rise in illicit drug overdose deaths in the province of British Columbia (BC), Canada, led to the declaration of a public health emergency. Due to the compounding historical and ongoing impacts of colonialism, including trauma and inequitable access to health servic…
Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada
Addiction and Heroin-Assisted Treatment: Legal Discourse and Drug Reform
This article analyzes the arguments put forth over a 3-day period at an injunction hearing, Providence Health Care Society v. Canada, held March 13–15, 2014 in Vancouver, British Columbia. The plaintiffs sought broad interlocutory relief from the Court for the provision of prescription heroin if requested by their physicians. This article fills an identified gap in scholarship by analyzing the civil Charter challenge, including the notice of civi…
No prominent works on this page.
Addiction and Heroin-Assisted Treatment: Legal Discourse and Drug Reform
This article analyzes the arguments put forth over a 3-day period at an injunction hearing, Providence Health Care Society v. Canada, held March 13–15, 2014 in Vancouver, British Columbia. The plaintiffs sought broad interlocutory relief from the Court for the provision of prescription heroin if requested by their physicians. This article fills an identified gap in scholarship by analyzing the civil Charter challenge, including the notice of civi…
Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada
Putting Indigenous Harm Reduction to Work: Developing and Evaluating “Not Just Naloxone”
First Nations people and communities have long been championing the provision of holistic, self-determining, culturally safe, and responsive health care. In April 2016, a catastrophic rise in illicit drug overdose deaths in the province of British Columbia (BC), Canada, led to the declaration of a public health emergency. Due to the compounding historical and ongoing impacts of colonialism, including trauma and inequitable access to health servic…
Just have this come from their prescription pad: The medicalization of safer supply from the perspectives of health planners in BC, Canada
Context In March 2020, British Columbia introduced the Risk Mitigation Guidance (RMG) to enable the prescription of pharmaceutical substitutes for the unregulated drug market to decrease overdose deaths and COVID-19 infections. This study presents health planners’ perspectives on the RMG adoption within a medicalized system of care.Methods We conducted interviews with 28 health planners to obtain their views on implementation. We undertook a them…
A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada
Our findings demonstrate the value of including fentanyl patch safer supply in the substance use continuum of care and offer insights for innovations in delivery of this intervention
Two-Eyed Seeing in Knowledge Synthesis: Weaving together Western scoping review methods with Indigenous storytelling to explore Indigenous approaches to harm reduction
Using methodological approaches rooted in Indigenous ways of knowing and being can help to ensure that research findings are relevant and useful to Indigenous communities, while providing evidence for more responsive public health policy and practice. This article explores a practical application of a Two-Eyed Seeing approach in knowledge synthesis as part of Phase I of the First Nation Health Authority’s Indigenizing Harm Reduction Study. The St…
Implementation Barriers and Outcomes of a Provincial Prescribed Safer Supply Initiative among Indigenous People who use Substances amid Covid-19 and a Toxic Drug Crisis in British Columbia, Canada
Background: In 2020, British Columbia (BC) introduced Risk Mitigation Guidance to support the provision of prescribed safer supply (PSS) to people at risk of toxic drug harms and death amid the COVID-19 pandemic. We sought to assess the self-reported barriers to and outcomes of PSS among Indigenous people who sought or accessed a prescription. Methods: Cross-sectional and longitudinal surveys with up to 5 time points per participant over 3 months…
Implementation of risk mitigation prescribing during dual public health emergencies: A qualitative study among Indigenous people who use drugs and health planners in Northern British Columbia, Canada
Implementation and access to risk mitigation prescribing in Northern BC was limited, with region-specific applicability challenges and a health service delivery model that was not able to sufficiently meet the unique service needs of IPWUD. Demonstrating Northern ingenuity, peer groups, harm reduction community champions, and telehealth services were identified as stopgap measures that promoted access and reduced inequitable implementation within…
Problem representation of the Risk Mitigation Guidance (RMG) within the context of dual public health emergencies of Covid-19 and toxic drug deaths in British Columbia, Canada
Our study builds on the importance of evaluating problem representations in the process of policymaking. The RMG illustrates how crisis-driven policymaking shapes problem representations, enabling rapid intervention through the COVID-19 response while constraining responses to the toxic drug emergency. As a medicalized emergency response, the RMG addressed contagion but failed to confront the structural drivers of toxic drug deaths. Our study hig…
HIV, Drug Use, Sexual Risk (6 works) · Medicine (6 works) · Opioid Use Disorder Treatment (6 works) · Indigenous (4 works) · Political science (4 works) · Psychiatry (4 works) · Public health (4 works) · SAFER (4 works) · Drug (3 works) · Harm (3 works)